Location History:
- Brookline, MA (US) (2009)
- London, GB (2011)
Company Filing History:
Years Active: 2009-2011
Title: Petr Cherepanov: Innovator in Antiviral Research
Introduction
Petr Cherepanov is a distinguished inventor based in London, GB. He has made significant contributions to the field of antiviral research, particularly in the development of nucleic acid molecules and integrase interacting proteins. With a total of 2 patents, his work has the potential to impact the treatment of viral infections.
Latest Patents
Cherepanov's latest patents include innovative approaches to understanding and combating viral integrase. The first patent focuses on nucleic acid molecules that specifically interact with the nucleic acid encoding the LEDGF/P75 protein. This invention provides methods and uses for these nucleic acid molecules, which could be crucial in antiviral therapies. The second patent presents integrase interacting proteins, including cofactors that enhance the strand transfer activity of HIV integrase. This invention also outlines methods for identifying molecules that interact with these proteins, paving the way for new antiviral strategies.
Career Highlights
Petr Cherepanov is affiliated with K.U. Leuven Research & Development, where he continues to advance his research in the field of virology. His work is characterized by a commitment to understanding the mechanisms of viral infections and developing effective treatments.
Collaborations
Cherepanov has collaborated with notable researchers in his field, including Zeger Debyser and Erik De Clercq. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in antiviral research.
Conclusion
Petr Cherepanov's contributions to antiviral research through his patents and collaborations highlight his role as an innovator in the field. His work continues to inspire advancements in the treatment of viral infections.